It's well before midday but chemical technician trainer Ralf Scharf is already heading to the company canteen. And lunch is the last thing on his mind.
BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.
German Covid-19 vaccine maker BioNTech said
Wednesday it has started production at its new facility in Marburg, expected
to significantly boost the EU's vaccine supply.
German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses.
German firm BioNTech warned Tuesday
there is no data backing the "safety and efficacy" of delaying the second shot
of its Covid-19 vaccine beyond three weeks, as some countries push back the jab to give more people their first dose.
The first doses of the Pfizer/BioNTech coronavirus vaccine have now been delivered to all of Germany's 16 states, the country's DPA news agency has reported, ahead of the first vaccinations on Sunday
It was over breakfast on the wintry morning of January 24 that Ozlem Tureci and her husband Ugur Sahin decided, "we need to fire the starting gun on this".
Progress on a Covid-19 vaccine has propelled the modest husband-and-wife team behind German firm BioNTech into
the global limelight, with attention inevitably focusing on their background as the children of Turkish immigrants.
The small German biotech firm BiOnTech, started by a husband and wife team with Turkish roots is in the world's press due a vaccine breakthrough. Here's what you need to know.
Germany's BioNTech, one of the
lead contenders in the race to develop a coronavirus vaccine, said Thursday it
was buying a new manufacturing site to quickly ramp up production once its
vaccine gets the green light.
